Arcadia Biosciences, Inc. financial data

Symbol
RKDA on Nasdaq
Location
202 Cousteau Place, Suite 105, Davis, US
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 433 % -26.5%
Quick Ratio 39 % -40.9%
Debt-to-equity 51.6 % -5.39%
Return On Equity -51.9 % +40.3%
Return On Assets -34.1 % +39.2%
Operating Margin -180 % +44%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.36M shares +22.9%
Common Stock, Shares, Outstanding 1.36M shares +22.9%
Entity Public Float 4.17M USD -80.2%
Common Stock, Value, Issued 65K USD 0%
Weighted Average Number of Shares Outstanding, Basic 1.36M shares +0.31%
Weighted Average Number of Shares Outstanding, Diluted 1.36M shares +0.31%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 5.6M USD +116%
Research and Development Expense 1.29M USD +43.4%
Costs and Expenses 15.7M USD +43.4%
Operating Income (Loss) -10.1M USD -20.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.18M USD -85%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -5.83M USD +62.1%
Earnings Per Share, Basic -1.18 USD/shares +37.6%
Earnings Per Share, Diluted -1.18 USD/shares +37.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.94M USD -62.9%
Accounts Receivable, after Allowance for Credit Loss, Current 3.85M USD +236%
Inventory, Net 835K USD -68.6%
Assets, Current 10.7M USD -46.5%
Property, Plant and Equipment, Net 55K USD -88.2%
Operating Lease, Right-of-Use Asset 306K USD -73.3%
Intangible Assets, Net (Excluding Goodwill) 39K USD -2.5%
Other Assets, Noncurrent 164K USD -9.39%
Assets 15.2M USD -35.1%
Employee-related Liabilities, Current 1.3M USD -5.1%
Liabilities, Current 2.33M USD -40.1%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 2M USD 0%
Liabilities 5.09M USD -36.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 117K USD +34.5%
Retained Earnings (Accumulated Deficit) -275M USD -2.17%
Stockholders' Equity Attributable to Parent 10.3M USD -33.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 10.1M USD -34.1%
Liabilities and Equity 15.2M USD -35.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.21M USD +7.39%
Net Cash Provided by (Used in) Financing Activities 5.51M USD
Net Cash Provided by (Used in) Investing Activities 4M USD +1170%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 1.36M shares +22.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.2M USD -236%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 30.5M USD +13.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 346K USD -72.8%
Depreciation 173K USD -36.9%
Payments to Acquire Property, Plant, and Equipment 13K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.8M USD +37%
Lessee, Operating Lease, Liability, to be Paid 1.04M USD -51.4%
Property, Plant and Equipment, Gross 1.91M USD -41.7%
Operating Lease, Liability, Current 346K USD -62.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 156K USD -82.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 886K USD -19.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 35K USD -72.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 156K USD -84%
Deferred Tax Assets, Operating Loss Carryforwards 23.2M USD +17.8%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 0 USD -100%
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 30.7M USD +12.6%
Interest Expense 12K USD -77.4%